Midwife Licensure Exam Normal Pregnancy, Labor & Postpartum — Normal Pregnancy: Physiologic & Psychological ChangesStudy Notes

The signs of pregnancy are classified into three categories based on their reliability and the mechanism by which they confirm pregnancy. This classification is fundamental to your assessment as a nurse, as it guides both patient counseling and referral decisions in primary healthcare settings across the Philippines. **Presumptive Signs (Subjective; Least Reliable)** These signs are experienced by the pregnant woman herself and are called 'presumptive' because they can have multiple other causes. They are the earliest manifestations but have the lowest diagnostic value. A woman presenting with presumptive signs alone does not yet have a confirmed pregnancy diagnosis. • Amenorrhea (missed period) — typically the first sign; assume pregnancy until proven otherwise in a woman of reproductive age with a missed period and recent sexual activity • Nausea and vomiting (morning sickness) — caused by rising hCG levels; peaks around 8–12 weeks; absent in ~30% of pregnancies • Breast tenderness and enlargement — from hormonal stimulation (estrogen and progesterone) • Urinary frequency — early sign from the growing uterus pressing on the bladder; decreases mid-pregnancy, returns in third trimester • Fatigue — from progesterone and increased metabolic demands; significant especially in first trimester • Quickening — first maternal perception of fetal movement, occurs ~18–20 weeks in primigravidas, ~16 weeks in multigravidas; teaches the woman to recognize her baby's patterns Clinical Pearl: In the Philippine context where many women use traditional methods for pregnancy detection, you must educate that presumptive signs alone are insufficient for confirmation. Women presenting to rural health units or barangay health centers with only presumptive signs should be referred for confirmatory testing (hCG) and/or ultrasound at secondary facilities when available. **Probable Signs (Objective; Examiner-Observed; Still Not Conclusive)** These are physical findings detected by a healthcare provider during examination. They indicate pregnancy is likely, but rare non-pregnant conditions can mimic them, so they are not diagnostic alone. • Goodell's sign — softening of the cervix (felt on digital cervical exam); the cervix becomes bluish-red and velvetlike from increased vascularity; typically positive by 4–6 weeks • Hegar's sign — softening of the lower uterine segment (isthmus) between the cervix and uterine fundus, detected by bimanual palpation (one hand on abdomen, one finger in cervix); often first apparent around 8–12 weeks • Chadwick's sign — bluish-violet discoloration of the vagina, cervix, and perineum from increased vascularity; typically positive by 6–8 weeks; the color intensifies as pregnancy advances • Ballottement — rebound of the fetus when the lower uterine segment is tapped from below (bimanual exam); detectable from ~16 weeks; indicates the fetus is freely floating in amniotic fluid • Braxton Hicks contractions — painless, irregular, involuntary uterine contractions beginning around 6 weeks but usually not felt by the woman until second/third trimester; frequency and intensity increase near term; distinguished from true labor contractions (which are regular, progressive, and painful) • Enlargement of the uterus and abdomen — progressive increase in uterine size and abdominal girth; by 12 weeks the fundus is palpable above the symphysis pubis • Positive serum or urine hCG (human chorionic gonadotropin) test — detects the hormone produced by trophoblastic tissue; serum hCG is more sensitive than urine; can be positive as early as 6–8 days after ovulation (before a missed period); labeled 'probable' rather than 'positive' because rare hydatidiform moles and choriocarcinomas also produce hCG • Pigmentation changes — darkening of the areolae, linea nigra, chloasma/melasma Clinical Pearl: In Philippines, presumptive + probable signs are often sufficient for the woman to initiate prenatal care at a rural health unit. However, confirmation with early ultrasound (when available) or serum hCG is the gold standard, especially to confirm viability and rule out ectopic pregnancy. **Positive Signs (Diagnostic; Only These Confirm Pregnancy)** These three signs can only occur in pregnancy and are 100% diagnostic. If even one is present, pregnancy is confirmed. • Fetal heart tones (FHT) audible — the beating heart of the fetus, audible by electronic Doppler by ~10–12 weeks gestation; audible by traditional fetoscope by ~18–20 weeks; normal FHR is 110–160 bpm; tachycardia or bradycardia warrants investigation for fetal distress or congenital anomalies • Fetal movement palpated by the examiner — the nurse or clinician feels the fetus moving during abdominal palpation (distinct from quickening, which is felt by the mother); typically possible from ~20 weeks onward • Visualization of the fetus on ultrasound — the gold standard in modern obstetrics; fetal pole visible by transvaginal ultrasound as early as 5–6 weeks gestation; confirms intrauterine pregnancy, rules out ectopic pregnancy, and allows accurate dating Clinical Application: In the Philippine primary healthcare setting, when a woman presents with amenorrhea and presumptive signs, your first step is to facilitate urine or serum hCG testing. If positive and available, refer for ultrasound to confirm intrauterine pregnancy and rule out ectopic pregnancy (which carries high maternal mortality risk, especially in areas with limited emergency services). If ultrasound is unavailable, the woman should be counseled on danger signs (severe abdominal pain, vaginal bleeding) and advised to seek care immediately if they occur.

Pregnancy induces profound, coordinated physiologic adaptations across all maternal body systems. These changes begin immediately after implantation and escalate throughout pregnancy, peaking near term. Understanding these changes is essential for several reasons: (1) they are normal and expected, and the nurse must reassure the woman that they are not signs of disease; (2) they can exacerbate existing health conditions (e.g., diabetes, hypertension); (3) they form the basis for common discomforts and self-care education; and (4) abnormal variants of these changes (e.g., severe hypertension) signal danger and require intervention. The changes are largely driven by the hormones estrogen and progesterone, the placental hormone human placental lactogen (hPL), and the physical effects of the enlarging uterus. **Reproductive System Changes** The uterus undergoes the most dramatic transformation. Pre-pregnancy, the uterus is a small, pear-shaped pelvic organ weighing ~60–70 g with a capacity of ~4 mL. By term, it is a large, thin-walled muscular organ weighing ~1,000 g (14–15 times heavier) with a capacity of ~5–6 liters. The fundus rises from the pelvis, reaching the level of the symphysis pubis by 12 weeks, the umbilicus by 20 weeks, and the xiphoid process by 36 weeks. This growth is driven by hypertrophy (enlargement of existing muscle fibers) and hyperplasia (increase in the number of muscle fibers). The uterine blood flow increases dramatically from ~50 mL/min pre-pregnancy to ~500–750 mL/min at term, supplying oxygen and nutrients to the pregnant uterus, placenta, and fetus. The cervix softens (Goodell's sign) and increases in vascularity, becoming bluish (Chadwick's sign). Cervical glands secrete thick, tenacious mucus that forms a protective plug (operculum or mucus plug) in the cervical canal; this plug helps prevent ascending infection and is expelled at the onset of labor ("bloody show"). The cervix remains firm and closed throughout pregnancy until late labor. The vagina elongates and its epithelium thickens and becomes more vascular. Vaginal secretions increase markedly (leukorrhea), becoming thicker and milky-white due to increased mucus production and shedding epithelial cells; this is normal and expected. The woman should be taught to report abnormal discharge (greenish, frothy, foul-smelling, or associated with itching or burning), as these suggest infection (e.g., trichomoniasis, bacterial vaginosis, candidiasis), which requires treatment during pregnancy to reduce risks of preterm labor and ascending infection. The vulva and perineum become increasingly vascular and edematous, particularly in the third trimester. Perineal varicosities may develop. These changes increase the risk of trauma during delivery but also aid in tissue stretching during the second stage of labor. Clinical Pearl: In the Philippine context, many women have not had prior pelvic exams or cervical cancer screening. Prenatal visits provide an opportunity for screening and health education. Normalize the softening of the cervix and increased discharge, as many women fear these changes signal infection or premature labor. **Cardiovascular System Changes** The cardiovascular system undergoes profound adaptations to meet the increased metabolic demands of pregnancy and prepare for blood loss at delivery. Blood volume increases progressively by approximately 40–50% (up to 1.5 liters additional volume in a 70 kg woman), peaking near term. This increase is composed of both plasma and red blood cells, but plasma increases more than RBCs (a disproportionate increase). Because RBC mass does not increase proportionally, the hemoglobin concentration and hematocrit fall—this dilutional effect is called the "physiologic anemia of pregnancy" and is normal. Anemia in pregnancy is defined as hemoglobin <11 g/dL in the first or third trimester, or <10.5 g/dL in the second trimester (lower threshold in second trimester due to greater hemodilution). The mechanism of this anemia is understood as an adaptive response: the increased plasma volume increases blood viscosity favorably for oxygen delivery to the fetus and reduces maternal-fetal vascular resistance. Iron supplementation is routine in pregnancy to support RBC production and prevent iron-deficiency anemia, which is distinct from physiologic anemia. Cardiac output (stroke volume × heart rate) increases 30–50% during pregnancy. This is achieved through an increase in stroke volume (the heart pumps more blood per beat) and an increase in heart rate of 10–15 bpm above baseline. A resting heart rate of 80–90 bpm is normal in the third trimester. The increased cardiac output is necessary to perfuse the placenta and maintain adequate oxygenation of the fetus and maternal organs despite the lower hemoglobin. Blood pressure typically decreases slightly, particularly in the second trimester, then returns toward pre-pregnancy baseline by term. A rise in systolic BP of >30 mmHg or diastolic BP of >15 mmHg above baseline, or an absolute reading of ≥140/90 mmHg, is abnormal and suggests gestational hypertension or pre-eclampsia and requires investigation. Blood pressure should be measured at each prenatal visit in the same arm, in a seated position after 5 minutes of rest, using an appropriately sized cuff. Supine hypotensive (vena cava) syndrome occurs when the heavy uterus compresses the inferior vena cava (IVC) when the woman lies supine, reducing venous return to the heart and causing a sudden drop in cardiac output. The woman experiences lightheadedness, dizziness, nausea, pallor, and hypotension. The remedy is immediate: position the woman on her left side (or at least tilted to one side) to relieve the compression. This is why left-lateral positioning is recommended for rest, sleep, and fetal monitoring in the third trimester. Educate the woman to avoid prolonged supine positioning, especially in late pregnancy, and to change positions frequently. Hypercoagulability (increased tendency to clot) develops progressively during pregnancy due to increases in clotting factors (I, II, VII, VIII, IX, X, XII), platelets, and fibrinogen, and decreases in natural anticoagulants (protein S). This protects against hemorrhage at delivery but increases the risk of deep vein thrombosis (DVT), pulmonary embolism (PE), and stroke. Risk factors for thromboembolism in pregnancy include immobility (bed rest, long flights), cesarean delivery, maternal thrombophilia, obesity, and advanced maternal age. Early mobilization, adequate hydration, and compression stockings (if indicated) are preventive measures. In the Philippines, where many women travel long distances to reach healthcare facilities, counseling on avoiding prolonged sitting and maintaining hydration during travel is important. Clinical Pearl: Explain to the pregnant woman that her slightly lower hemoglobin (physiologic anemia) is normal and expected, not a sign of disease. Emphasize that she should take iron supplements as prescribed and eat iron-rich foods (red meat, poultry, beans, dark leafy greens). Counsel on avoiding prolonged supine positioning and on changing positions frequently. If she reports dizziness or palpitations, assess for anemia, infection, or other complications. **Respiratory System Changes** Maternal oxygen consumption increases ~15–20% during pregnancy to meet the metabolic demands of the enlarged uterus, increased cardiac output, and the growing fetus. To achieve this increased oxygenation, several respiratory changes occur. Progesterone, which rises progressively throughout pregnancy, stimulates the respiratory center in the medulla, causing the woman to breathe deeper (increased tidal volume by ~30–40%). This increased minute ventilation occurs without an increase in respiratory rate, so the woman maintains normal breathing frequency (12–18 breaths/min) but each breath is deeper. The result is a mild respiratory alkalosis (elevated pH, low PaCO2) that is normal and not clinically significant. This enhanced ventilation is considered an adaptation to eliminate fetal CO2 via the placental circulation. The diaphragm is progressively displaced upward by the enlarging uterus, but diaphragmatic excursion (the distance the diaphragm moves with each breath) increases to compensate. The anteroposterior and transverse diameters of the thorax increase, and the rib cage widens. Despite these compensatory changes, the woman often reports dyspnea (shortness of breath), which is normal in pregnancy and occurs in ~70% of pregnant women by the third trimester. This dyspnea is NOT due to oxygen deprivation; it is due to the increased work of breathing and the sensation of breathlessness from the enhanced minute ventilation. Reassure the woman that dyspnea in pregnancy is normal and usually resolves postpartum. Mucosal edema of the upper respiratory tract (nose, mouth, pharynx) is common, caused by increased blood flow to these tissues and hormonal effects. This leads to nasal stuffiness (nasal congestion), epistaxis (nosebleeds), voice changes, and difficulty with nasal breathing. The woman should be advised to use saline nasal drops or spray, sleep with the head elevated, and avoid nasal decongestants unless prescribed. Epistaxis should be managed with gentle pressure and saline irrigation; severe or recurrent epistaxis is uncommon and should prompt investigation. Asthma may worsen, improve, or remain unchanged during pregnancy; women with asthma should continue their maintenance medications and be monitored closely. Upper respiratory tract infections should be treated promptly to prevent progression to pneumonia. Clinical Pearl: Many pregnant women are frightened by dyspnea, fearing it indicates cardiac disease or fetal distress. Reassure them that dyspnea is normal in pregnancy, caused by progesterone-driven deeper breathing and the mechanical effects of the uterus on the diaphragm. Teach them to report dyspnea that is worse when lying flat (orthopnea), associated with chest pain or palpitations, or accompanied by cough and fever, as these may indicate cardiac or pulmonary complications. **Gastrointestinal System Changes** The GI system undergoes significant changes that explain many common discomforts of pregnancy. Nausea and vomiting (morning sickness) occur in 50–80% of pregnant women, typically beginning around 4–6 weeks gestation and peaking at 8–12 weeks, then gradually resolving by 16–20 weeks (though some women experience it throughout pregnancy). The etiology is not completely understood but is believed related to rising hCG levels, changes in gastric motility, and psychological factors. The nausea is usually mild and does not prevent eating, though some women experience severe hyperemesis gravidarum (persistent vomiting with weight loss, dehydration, and electrolyte imbalances), which requires medical intervention. Heartburn (pyrosis) occurs in 30–50% of pregnancies, typically beginning in the second or third trimester. The mechanism is multifactorial: progesterone relaxes the gastroesophageal sphincter (allowing reflux of gastric contents), the enlarging uterus increases intra-abdominal pressure, and delayed gastric emptying slows digestion. Pregnant women should be advised to eat small, frequent meals; remain upright for 1–2 hours after eating; avoid fatty, spicy, or acidic foods and beverages; and sleep with the head elevated. Antacids (calcium carbonate, magnesium hydroxide) are safe; H2 blockers (ranitidine, famotidine) are also considered safe in pregnancy; proton pump inhibitors should be used judiciously. Sodium bicarbonate should be avoided due to the risk of alkalosis and fetal effects. Constipation affects 30–40% of pregnant women, caused by progesterone-induced slowing of intestinal motility (peristalsis) and the mechanical pressure of the enlarging uterus on the colon and rectum. Oral iron supplementation can worsen constipation. Management includes increasing dietary fiber (fruits, vegetables, whole grains), increasing fluid intake (8–10 glasses of water daily), regular physical activity, and responding promptly to the urge to defecate. If needed, stool softeners (docusate) or bulk laxatives (psyllium) are safe; stimulant laxatives should be avoided. The woman should be reassured that constipation is common and not harmful to the fetus. Hemorrhoids (varicose veins of the rectum and anus) occur in ~25% of pregnancies, resulting from constipation, increased intra-abdominal pressure, and increased blood volume. They may be painless or cause itching, burning, pain, or bleeding. Management includes prevention and treatment of constipation, warm sitz baths, topical anesthetic creams, and witch hazel compresses. Severe hemorrhoids may persist postpartum; surgical intervention is rarely needed in pregnancy. Ptyal ism (excessive salivation) occurs in some pregnant women, usually in the first trimester. The cause is unknown, but it may be related to increased oral mucus production or difficulty swallowing due to nausea. No specific treatment is needed; it usually resolves spontaneously. Pica (compulsive craving and eating of non-food substances) occurs in some pregnancies, particularly in women from certain cultural backgrounds or with specific nutrient deficiencies (iron, zinc). Common pica cravings include clay, starch (cornstarch, laundry starch), ice, dirt, and chalk. Pica can be harmful (lead poisoning from contaminated clay, intestinal obstruction, parasitic infection). The nurse should assess for pica, investigate underlying nutrient deficiencies (particularly iron), and educate on the risks. In the Philippine context, pica is not uncommon; approach it non-judgmentally and address underlying nutritional needs. Appetite and food preferences often change during pregnancy. Some women develop aversions to foods they previously enjoyed, particularly protein and spicy foods (which may be cultural staples in Philippines). Strong food cravings are common, though most are not based on nutritional need. Support the woman's preferences while encouraging a balanced, nutritious diet. Clinical Pearl: Normalize nausea and constipation as common, expected changes; teach the woman practical self-care measures (small frequent meals, fiber, fluids, positioning). Screen for hyperemesis gravidarum (persistent vomiting, weight loss >5% pre-pregnancy weight) and refer for medical management. Address pica non-judgmentally; screen for iron deficiency and other nutritional deficiencies. **Renal and Urinary System Changes** The kidneys and urinary tract undergo significant changes during pregnancy, with important clinical implications. Glomerular filtration rate (GFR) increases by 40–50% starting in the first trimester and remaining elevated throughout pregnancy and into the early postpartum period. This increased GFR results in increased filtration of creatinine and urea, so serum creatinine and blood urea nitrogen (BUN) decrease (a serum creatinine >0.8 mg/dL or BUN >15 mg/dL in a pregnant woman may indicate renal impairment and should be investigated). This increased GFR is due to increased renal blood flow and increased glomerular capillary hydrostatic pressure. The clinical benefit is enhanced clearance of metabolic wastes, protecting both mother and fetus. Urinary frequency increases in the first and third trimesters due to increased blood volume and GFR in early pregnancy, and due to fetal pressure on the bladder in the third trimester. The woman may need to urinate 10–15 times daily. This is normal and expected (except when accompanied by dysuria or fever, which suggest UTI). Reassure the woman that frequency decreases in the second trimester when the uterus rises out of the pelvis into the abdomen. Glycouria (glucose in the urine) can occur with normal blood glucose in pregnancy due to increased GFR and the kidney's decreased threshold for reabsorbing glucose. However, persistent glycosuria (on multiple occasions) warrants screening for gestational diabetes mellitus (GDM) with a glucose tolerance test. Proteinuria (protein in urine) can also increase in pregnancy, up to 300 mg/day being considered normal (compared to <150 mg/day in non-pregnant women). Greater proteinuria warrants investigation for preeclampsia (especially if accompanied by hypertension and edema) or other renal disease. The ureters and renal pelves undergo dilation (hydronephrosis of pregnancy) starting around 6 weeks, peaking at 20–24 weeks, and usually resolving by 6–8 weeks postpartum. The mechanism is thought to be progesterone-induced relaxation of ureteral smooth muscle and mechanical compression of the ureters by the enlarged uterus, placenta, and increased blood volume. This dilation increases the risk of urinary stasis and pyelonephritis (upper urinary tract infection). Asymptomatic bacteriuria (bacteria in the urine without symptoms) should be screened for and treated in pregnancy (unlike in non-pregnant women) because of the increased risk of progression to pyelonephritis, which can trigger preterm labor. Typical screening includes a clean-catch urine culture at the first prenatal visit. Clinical Pearl: Teach the woman that urinary frequency is normal in early and late pregnancy and is not a sign of UTI. However, she should report dysuria (painful urination), fever, flank pain, or urgency/frequency with other symptoms, as these suggest UTI or pyelonephritis and require antibiotic treatment. Encourage adequate fluid intake to prevent urinary stasis and UTI. **Integumentary System Changes** The skin undergoes notable changes during pregnancy, most of which are benign and temporary. Striae gravidarum (stretch marks) develop in 50–90% of pregnancies, appearing as reddish or purplish linear marks, usually on the abdomen, breasts, thighs, and buttocks. They result from stretching of the skin and rupture of collagen and elastic fibers in the dermis, exacerbated by increased cortisol levels. No intervention prevents them, though keeping skin moisturized may help. They typically fade to silvery-white marks in the postpartum period but do not fully resolve. Reassure the woman that striae are very common and do not indicate a problem. Linea nigra (dark line) is a darkening of the linea alba (the midline of the abdomen from the umbilicus to the symphysis pubis). It appears in ~75% of pregnancies, usually by the second trimester, and is caused by increased melanin production. The line typically fades within a few months postpartum. It is more prominent in women with darker skin tones. Chloasma (also called melasma or the "mask of pregnancy") is irregular brownish patches on the face, particularly on the cheeks, forehead, nose, and upper lip. It occurs in ~50% of pregnancies, more commonly in women with dark skin and those exposed to sun. It is caused by increased melanin production and is exacerbated by sun exposure. Prevention includes use of sunscreen (SPF ≥30) and avoiding prolonged sun exposure. Chloasma usually fades after pregnancy but may persist in some women. Darkening of the areolae and nipples occurs as part of increased skin pigmentation. The areolae may also increase in size and develop small glands (Montgomery's tubercles, which produce lubricating oil during breastfeeding). These changes are normal preparation for breastfeeding. Hemangiomas (benign vascular tumors) may develop or enlarge during pregnancy due to increased estrogen, and typically regress postpartum. Spider angiomas (fine vascular markings resembling a spider) may appear on the face, neck, and upper chest due to increased estrogen. Hair and nail changes occur: some women experience thicker hair growth (due to prolonged anagen or growth phase), while others experience hair loss. Nails may become stronger or weaker and may develop transverse grooves. These changes reverse postpartum. Other skin changes include increased glandular activity (more oily skin or acne in some women, excessive sweating from increased metabolic rate), increased skin pigmentation overall, and occasional urticaria or eczema. Clinical Pearl: Reassure the woman that most integumentary changes are temporary and will fade postpartum. Advise her to use sunscreen and avoid excessive sun exposure to minimize chloasma. Explain that striae are a normal consequence of skin stretching and do not indicate inadequate hydration or poor nutrition (common myths in some cultures). **Musculoskeletal System Changes** The musculoskeletal system undergoes changes that prepare the pelvis for birth and accommodate the shifting center of gravity. Relaxin, a hormone produced by the corpus luteum and later by the placenta, acts to relax ligaments and cartilage throughout the body, particularly in the pelvis. This hormone, combined with progesterone, causes softening and increased mobility of the sacroiliac joints, pubic symphysis, and other joints. This increased joint laxity is protective—it allows the pelvis to expand during labor—but it also causes musculoskeletal discomfort and altered gait. Postural changes occur as the enlarging uterus and breasts shift the center of gravity forward. The woman typically responds by increasing lumbar lordosis (exaggeration of the normal curve of the lower spine), a posture sometimes called the "pride of pregnancy." This anterior shift can cause or exacerbate lower back pain and neck strain. Some women also develop anterior pelvic tilt, knee hyperextension, and a characteristic waddling gait (sometimes called a "penguin walk") in the third trimester. Back pain is very common, affecting ~50% of pregnant women, particularly in the second and third trimesters and in women with prior back problems. It is usually localized to the lumbar region and may be accompanied by pelvic girdle pain (pain in the symphysis pubis or sacroiliac joints). Predisposing factors include poor posture, weak abdominal muscles, heavy physical labor, and the shift in center of gravity. Management of back pain includes maintaining good posture (shoulders back, head aligned over shoulders), pelvic tilt exercises (contracting abdominal muscles to tilt the pelvis and reduce lumbar lordosis), low-heeled shoes (not flat or high heels), firm mattress for sleeping, warm compresses or massage, and activity modification (avoiding heavy lifting, prolonged sitting or standing, and bending from the waist). In the Philippines, where many women engage in manual labor or have limited access to labor-saving devices, education on body mechanics and encouragement to rest when possible are important. Diastasis recti (separation of the rectus abdominis muscles) is common in the third trimester and postpartum. The muscles separate along the linea alba to accommodate the enlarging uterus, and they typically re-approximate in the first 6 weeks postpartum (though they may persist longer or be more pronounced with multiple pregnancies or advanced maternal age). Joint swelling and stiffness may occur, particularly in the hands, feet, and knees, due to fluid retention and joint laxity. Usually resolves postpartum. Clinical Pearl: Educate on posture, pelvic tilt exercises, appropriate footwear, and activity modification to prevent or minimize back pain. Reassure that joint laxity and postural changes are temporary and will improve postpartum. Explain that the waddling gait is normal and expected, not a sign of weakness or disease. **Metabolic and Endocrine Changes** Metabolic rate increases ~15–25% during pregnancy to support the increased energy demands of the enlarged uterus, increased cardiac output, and fetal growth. Most of this energy goes to synthesis of fetal and placental tissues and increased maternal fat stores. Weight gain during pregnancy is an important indicator of maternal and fetal health. The Institute of Medicine recommends: • Underweight women (BMI <18.5): 28–40 lbs (12.7–18.1 kg) • Normal weight women (BMI 18.5–24.9): 25–35 lbs (11.4–15.9 kg) • Overweight women (BMI 25–29.9): 15–25 lbs (6.8–11.4 kg) • Obese women (BMI ≥30): 11–20 lbs (5–9.1 kg) Inadeduate weight gain is associated with fetal growth restriction and preterm birth; excessive weight gain increases the risk of gestational diabetes, hypertension, and cesarean delivery. Most weight gain occurs in the second and third trimesters. Distribution of the 25–35 lbs in a normal-weight woman is approximately: fetus (3.5 lbs), placenta (1.5 lbs), amniotic fluid (2 lbs), increased uterine weight (2.5 lbs), increased blood volume (3.5–4 lbs), increased breast tissue (0.75–1 lbs), and increased maternal fat stores (7–8 lbs). The remaining weight is water retention and extravascular fluid. Carbohydrate metabolism changes to ensure adequate glucose delivery to the fetus. In early pregnancy, insulin sensitivity increases, but in the second and third trimesters, insulin resistance develops due to hPL (human placental lactogen), cortisol, and other hormones. This resistance shunts more glucose to the fetus (which is glucose-dependent) and forces the mother to rely more on fat for energy. The result is a mild fasting hypoglycemia (lower fasting blood glucose in pregnancy than in non-pregnant state), which is normal and not harmful. The increased insulin resistance, combined with increased insulin demand, can precipitate gestational diabetes mellitus (GDM) in women with inadequate beta-cell reserve. Screening for GDM typically occurs at 24–28 weeks with a 50-gram glucose challenge test (GCT), followed by a 3-hour glucose tolerance test (GTT) if the GCT is ≥140 mg/dL (or ≥135 mg/dL in some protocols). Lipid metabolism also changes: total cholesterol increases ~25–30% (largely HDL and LDL), and triglycerides increase ~30–40%, peaking in the third trimester. These increases are normal and not indicative of dyslipidemia; they revert to baseline postpartum. The increased lipids may reflect increased energy availability for fetal and maternal tissues. Hormonal changes are profound: • hCG (human chorionic gonadotropin): Produced by the trophoblast immediately after implantation, peaks at 8–10 weeks (~100,000 IU/L), then declines to lower, stable levels by ~16 weeks. hCG maintains the corpus luteum, which produces progesterone in early pregnancy until the placenta takes over at ~12 weeks. hCG is the hormone detected by pregnancy tests. Rising hCG levels are thought to contribute to morning sickness. • Estrogen: Produced primarily by the corpus luteum early in pregnancy, then increasingly by the placenta and fetal adrenal glands (as estrone and estriol). Estrogen rises progressively throughout pregnancy, peaking at term. It stimulates breast tissue growth, increases blood volume, increases coagulation factors, relaxes smooth muscle (contributing to vasodilation, decreased GI motility, and other effects), and affects glucose metabolism. Estriol is produced primarily in the third trimester and is highest at term. • Progesterone: Produced by the corpus luteum in the first 12 weeks, then by the placenta. Progesterone rises progressively throughout pregnancy. It maintains the endometrium, relaxes smooth muscle (decreasing GI motility, ureteral peristalsis, and vascular tone), suppresses uterine contractions until late in pregnancy, increases minute ventilation, increases appetite, and contributes to warmth and fatigue. Progesterone is essential for maintaining pregnancy; deficiency can lead to miscarriage. • hPL (human placental lactogen): Produced by the placental syncytiotrophoblast, increases progressively throughout pregnancy. hPL causes insulin resistance and increases maternal blood glucose and lipids, thus "shunting" more nutrients to the fetus. hPL levels correlate with placental mass and can be used to assess placental function, though this is rarely done clinically. • Prolactin: Increases progressively throughout pregnancy under the influence of estrogen. High prolactin levels stimulate breast tissue growth and prepare the breasts for lactation. Oxytocin release (which would stimulate uterine contractions and milk letdown) is suppressed during pregnancy by progesterone but becomes active postpartum. • Oxytocin: The neurohypophyseal hormone responsible for uterine contractions and milk letdown. Maternal sensitivity to oxytocin increases dramatically in the third trimester and at labor onset, explaining why the same oxytocin levels cause no contractions in early pregnancy but strong, coordinated contractions at term. • Thyroid hormone: Thyroid-binding globulin (TBG) increases due to estrogen, so total T4 and T3 increase, but free T4 and T3 usually remain normal or decrease slightly. TSH may be slightly lower in early pregnancy due to hCG stimulation of thyroid hormone production. Pregnancy is a time of mild thyroid hormone excess, and some women (particularly those with marginal iodine intake) can develop gestational thyroiditis. Iodine requirements increase in pregnancy; adequate intake is important for fetal neurodevelopment. • Adrenal hormones: Cortisol increases, but so does cortisol-binding globulin, so free cortisol changes variably. ACTH also increases. These changes support adaptation to pregnancy but may exacerbate conditions like Cushing's syndrome or adrenal insufficiency. • Parathyroid hormone: Increases in pregnancy to meet increased calcium demands for fetal skeleton and maternal bone. Vitamin D metabolism is altered to increase intestinal calcium absorption. Clinical Pearl: Explain that weight gain is essential and healthy in pregnancy; inadequate intake and weight loss are harmful to the fetus. Discuss appropriate weight gain based on pre-pregnancy BMI. Screen for gestational diabetes at 24–28 weeks. Educate on the normal hormonal changes driving fatigue, mood changes, and appetite increases, so the woman understands these are biological adaptations, not personal failings.

Understanding fetal development is essential for the nurse's assessment of pregnancy progression, identification of critical periods of vulnerability, and accurate counseling of the pregnant woman regarding fetal milestones. Fetal development is traditionally divided into three stages based on the degree of differentiation and growth. **Pre-embryonic Stage (Weeks 1–2): Fertilization, Cleavage, and Implantation** Following fertilization of the ovum by the sperm, the zygote (1-cell stage) undergoes rapid mitotic division, producing a 2-cell stage (Day 1), 4-cell stage (Day 2), and 8-cell stage (Day 3). By Day 3, the pre-embryo enters the morula stage (a solid ball of 12–32 cells resembling a mulberry). By Day 5–6, the blastocyst stage is reached—a hollow sphere with an outer layer of trophoblast cells (which will form placental tissues) and an inner cell mass (which will form the embryo). The blastocyst travels down the fallopian tube and enters the uterine cavity by Day 5. Implantation (the process of the blastocyst embedding in the endometrial lining) begins around Day 6–7 and is complete by Day 10–12. By Day 7–8, the trophoblast differentiates into cytotrophoblast (inner layer) and syncytiotrophoblast (outer layer); the syncytiotrophoblast invades into the endometrium, creating small hemorrhagic lakes that become the intervillous spaces of the placenta. hCG is produced by the trophoblast and can be detected in the maternal serum by 6–8 days after ovulation (a few days before the missed period). The bilaminar disc forms, consisting of epiblast and hypoblast layers, which will differentiate into the three primary germ layers. Clinical significance: Implantation usually occurs in the fundus or upper uterine segment, but abnormal implantation sites (low implantation in placenta previa, implantation in scar tissue as in placenta accreta, or outside the uterus as in ectopic pregnancy) carry serious risks. Progesterone from the corpus luteum is essential for endometrial preparation and maintenance during this stage; inadequate progesterone increases miscarriage risk. **Embryonic Stage (Weeks 3–8): Organogenesis—Critical Period of Differentiation** This 6-week period is marked by the formation of all major organ systems—an extraordinarily complex process called organogenesis. This is the period of **greatest vulnerability to teratogens** (harmful agents causing birth defects), as critical differentiation and development are occurring rapidly and the embryo is particularly sensitive to disruption. Week 3: • The trilaminar disc forms, consisting of three primary germ layers: ectoderm (outer), mesoderm (middle), and endoderm (inner). These three layers give rise to all tissues and organs of the body. • The primitive streak appears, defining the cranial-caudal axis of the embryo. • Yolk sac is visible on transvaginal ultrasound. Week 4: • Neural tube forms (from ectoderm) → future brain and spinal cord. Closure of the neural tube is complete by week 4; failure results in neural tube defects (anencephaly, spina bifida). Adequate maternal folate is critical for neural tube closure; this is why folic acid supplementation (400–1,000 mcg daily) is recommended from preconception through the first trimester. • Heart tube forms and begins to beat (~3 weeks, sometimes visible on ultrasound). • Somites (segments) form → future vertebrae, ribs, and muscles. • Upper and lower limb buds appear. • Yolk sac and amniotic sac visible on ultrasound. Week 5: • Fetal heart begins to beat (~3–4 weeks) and is audible on transvaginal Doppler by 5–6 weeks (though often difficult to detect this early); by 10–12 weeks, easily heard on Doppler; by 18–20 weeks, audible on fetoscope. • Eye and ear development begins. • Limb buds elongate; hand and foot plates visible. Week 6: • Digits (fingers and toes) visible on ultrasound. • External genitalia begin to form (though sex not yet distinguishable). • Intestines hernia out of the body cavity and into the umbilical cord (physiologic herniation), then return by week 10. Week 7–8: • Sex of the embryo becomes externally distinguishable on ultrasound (genitalia visibly different), though genetic sex is determined at fertilization. Phenotypic sex differentiation involves action of testis-determining factor (TDF) on Y chromosome (in males) or its absence (in females). • All major organ systems have formed (organogenesis complete). • Embryo is ~3 cm (1.2 inches) long and weighs ~1 gram. • The embryo is now called a "fetus." Clinical pearl: The embryonic stage (weeks 3–8) encompasses the period of greatest teratogen vulnerability. Critical exposures during this window (to teratogenic drugs like isotretinoin for acne or thalidomide for morning sickness, to infections like rubella or zika, to alcohol, or to radiation) carry high risk of congenital anomalies. Counsel women who are planning pregnancy on folic acid supplementation, avoidance of teratogens, and immunization (especially rubella) before pregnancy. If a woman is exposed to a potential teratogen in the first trimester, she should be counseled based on the timing of exposure, the agent's known risks, and the specific developmental stage (critical periods vary for different organs). **Fetal Stage (Week 9 to Birth): Growth and Maturation** From week 9 onward, the organism is called a "fetus." This stage is characterized not by formation of new organ systems (all are already formed) but by growth and maturation of the structures formed in the embryonic stage. The fetus grows from ~1 gram at 8 weeks to ~3,500 grams (7.5 lbs) at 40 weeks—a 3,500-fold increase in weight. This growth is most rapid in the second and third trimesters. Week 9–12: • Fetus begins to move, though movements are not felt by the mother until 16–20 weeks. • Most of the primitive organs are now functional, though lungs, liver, and kidney cannot yet sustain life independently. • Crown-rump length (CRL) at 12 weeks is ~5–6 cm (2–2.4 inches). • Sex externally evident on ultrasound (though not always accurately distinguished in early scans). • Placenta is fully formed and functional by 12 weeks. Week 13–16: • Growth accelerates. • Fine motor movements develop; fetus moves frequently but still not felt by the mother. • Lanugo (fine, downy hair) begins to cover the skin. • Fingernails and toenails begin to form. • Fetal urine production begins; urine contributes to amniotic fluid volume. Week 17–20: • Quickening (first maternal perception of fetal movement) typically occurs around 18–20 weeks in a first pregnancy (earlier in multigravidas, around 16 weeks). This milestone is significant because it marks the woman's first conscious awareness of the fetus as a separate being and enhances maternal-fetal attachment. • Vernix caseosa (a white, greasy, protective coating) begins to form on the skin. • Fetus can suck thumb and open/close eyes. • Eyebrows and eyelashes develop. • Sweat glands form. • Fetal weight is ~300 grams (10.6 oz); length is ~19 cm (7.5 inches). Week 21–24: • Lungs begin producing surfactant (a substance essential for lung expansion after birth). Adequate surfactant production is key to extrauterine survival. • Lanugo completely covers the body. • Vernix caseosa thickens. • Age of viability (the gestational age at which the fetus could survive outside the uterus with intensive care) is approximately 24 weeks, though survival is rare and morbidity high. By 26–27 weeks, survival rates are substantially better. • Fetal weight is ~600 grams; length is ~23 cm. Week 25–28: • Eyes open. • Fetus responds to sound. • Respiratory movements (practice breathing) begin, though the lungs are still immature. • Testes descend in males (descent continues through birth and into the postnatal period). • Fetal weight is ~1,000 grams (1 kg); length is ~27 cm. Week 29–32: • Increased fat deposition; fetus appears rounder and more "babified." • Central nervous system develops further; increase in reflexes and coordinated movements. • Lungs continue to mature; surfactant production increases. • Lanugo begins to shed. • Fetal weight is ~1,500–2,000 grams; length is ~30–31 cm. Week 33–36: • Most lanugo is shed; vernix caseosa remains in skin folds. • Meconium (fetal stool) accumulates in the fetal intestines; appears as dark green material passed shortly after birth. • Fetal position often becomes vertex (head-down) by 34–36 weeks, optimal for vaginal delivery. Assessment of fetal position using Leopold's maneuvers is part of prenatal assessment from 36 weeks onward. • Fetal weight is ~2,200–2,500 grams; length is ~32–33 cm. Week 37–40+ (Term and Beyond): • Term is defined as 37–42 weeks; full term is 39–40 6/7 weeks. • Fetal skin is pink and smooth; lanugo is mostly shed. • Vernix caseosa is reduced but still present in skin folds. • Fetal nails extend to fingertips and toenails. • Majority of prenatal weight gain occurs in the third trimester; average term fetus weighs 3,400–3,600 grams (7.5–8 lbs); range is 2,500–4,500 grams for normal singleton pregnancies. • Fetal length at term is ~50–51 cm (19.7–20 inches), though length varies more than weight. • Fetus is ready for extrauterine life: lungs are mature with adequate surfactant, liver can handle conjugation and metabolism, kidneys can concentrate urine, nervous system can regulate temperature and breathing, and gastrointestinal system can digest and absorb milk. Clinical pearl: Fetal weight is the single most important predictor of neonatal survival and morbidity. Birth weights <2,500 grams are classified as low birth weight (LBW), <1,500 grams as very low birth weight (VLBW), and <1,000 grams as extremely low birth weight (ELBW). Preterm birth (delivery before 37 weeks) is associated with higher neonatal morbidity and mortality due to organ immaturity. The nurse assesses fetal weight using fundal height measurement and ultrasound (when available) to identify growth restriction (small for gestational age [SGA], often due to placental insufficiency, maternal hypertension, or maternal smoking) or excessive growth (large for gestational age [LGA], often due to maternal diabetes), both of which carry increased risks. Fetal weight gain in the third trimester should be approximately 200 grams (7 oz) per week; if fundal height growth slows or plateaus, further assessment is needed. **Placental and Umbilical Development** The placenta develops from trophoblastic tissue and is fully formed by 12 weeks gestation. It is the organ of exchange between maternal and fetal circulations, serving multiple functions: • **Respiratory exchange**: Maternal oxygen is transferred to fetal hemoglobin across the placental barrier; fetal CO2 is transferred back to maternal circulation. • **Nutrient transfer**: Glucose, amino acids, fatty acids, vitamins, minerals, and other nutrients are transferred from maternal to fetal circulation. • **Waste removal**: Fetal metabolic wastes (CO2, urea, creatinine) are transferred to maternal circulation for maternal elimination. • **Immunologic function**: Maternal antibodies (particularly IgG) are transferred to the fetus, providing passive immunity; this is why maternal infections can affect the fetus. • **Endocrine function**: The placenta produces hCG (early pregnancy), hPL, estrogen, and progesterone, which are essential for maintaining pregnancy and driving maternal adaptations. • **Barrier function**: The placental barrier (composed of syncytiotrophoblast, cytotrophoblast, and fetal endothelium) selectively restricts passage of certain substances (e.g., bacteria, larger molecules) while allowing passage of others (e.g., gases, small molecules, fat-soluble drugs). The umbilical cord connects the fetus to the placenta and contains two umbilical arteries (carrying deoxygenated fetal blood to the placenta) and one umbilical vein (carrying oxygenated blood from the placenta to the fetus). This anatomy is unique—arteries typically carry oxygenated blood, but umbilical arteries carry deoxygenated blood, and veins typically carry deoxygenated blood, but the umbilical vein carries oxygenated blood. The umbilical arteries originate from the fetal internal iliac (hypogastric) arteries; the umbilical vein enters the fetus at the umbilicus and continues to the ductus venosus (which bypasses the liver) and then to the IVC. Normally, there are two arteries and one vein (AVA), but in ~1% of pregnancies, a single umbilical artery (SUA) is present. An SUA is associated with increased risk of congenital anomalies, chromosomal abnormalities, and fetal growth restriction; close fetal surveillance is warranted. The amniotic fluid surrounds the fetus, providing a protective environment. Volume increases gradually throughout pregnancy, reaching ~500–800 mL at 20 weeks and ~800–1,000 mL (or more) at term. Amniotic fluid is produced by fetal urine (largest source), by respiratory and GI secretions, and by transudation from fetal skin and cord. Fluid is swallowed by the fetus and absorbed from the GI tract, recycling back to maternal circulation. Abnormal amniotic fluid volumes indicate problems: polyhydramnios (excess fluid, >2,000 mL at term) can indicate fetal anomalies (e.g., esophageal atresia, anencephaly), maternal diabetes, or hydrops fetalis; oligohydramnios (decreased fluid, <500 mL at term) suggests placental insufficiency, fetal growth restriction, renal anomalies, or ruptured membranes. Amniotic fluid volume is assessed by ultrasound using the amniotic fluid index (AFI) or single deepest vertical pocket (DVP) measurements. Clinical Pearl: If a pregnant woman has an ultrasound report noting a single umbilical artery, do not alarm her, but counsel that closer fetal surveillance (extra ultrasounds to assess growth and well-being) is recommended. Emphasize that many infants with SUA are born healthy with no complications. Similarly, if polyhydramnios or oligohydramnios is noted, explain what these mean, what they might indicate, and what further assessment is needed.

Accurate estimation of gestational age (how many weeks pregnant the woman is) and the estimated date of delivery (EDD, the predicted due date) is one of the most important clinical tasks in prenatal care. Accurate dating allows the nurse and obstetric team to: • Identify appropriate prenatal screening tests at the correct gestational age (e.g., neural tube defect screening at 15–20 weeks, GDM screening at 24–28 weeks). • Distinguish preterm birth (before 37 weeks) from term birth (37–42 weeks) and post-term birth (after 42 weeks), as each carries different perinatal risks. • Assess fetal growth (comparing actual weight to expected weight for gestational age). • Time elective cesarean delivery and labor induction appropriately. • Make decisions about interventions in high-risk pregnancies. Several methods exist for estimating gestational age, each with varying accuracy. The accuracy varies depending on the certainty of the dating information and the timing in pregnancy at which dating is performed. **Naegele's Rule: Calculation of EDD from Last Menstrual Period (LMP)** Naegele's rule is the most commonly used and simplest method for estimating EDD, particularly in low-resource settings where ultrasound may be unavailable. The rule is calculated as follows: **Count back 3 months from the first day of the last menstrual period (LMP), then add 7 days; if this crosses a year boundary, add 1 year.** Alternatively: **LMP − 3 months + 7 days (+ 1 year if year boundary crossed) = EDD** Example 1: If LMP is October 10, 2025: • Subtract 3 months: October 10 → July 10 • Add 7 days: July 10 + 7 = July 17 • Do not add 1 year (year boundary not crossed) • EDD = July 17, 2025 Example 2: If LMP is February 14, 2025: • Subtract 3 months: February 14 → November 14 (of the prior year, but we'll address that) • Actually, subtracting 3 months from February brings us to November of the PRIOR year: November 14, 2024 • Add 7 days: November 14 + 7 = November 21, 2024 • Add 1 year (because we subtracted backward and crossed a year boundary): November 21, 2024 + 1 year = November 21, 2025 • EDD = November 21, 2025 Naegele's rule assumes a regular 28-day menstrual cycle. If the woman's cycles are longer (e.g., 35 days), the EDD will be later; if cycles are shorter (e.g., 21 days), the EDD will be earlier. The rule also assumes ovulation occurs on day 14 of the menstrual cycle, which is average but varies among women. Accuracy of Naegele's rule: When the LMP date is certain and cycles are regular 28-day cycles, Naegele's rule is accurate within ±3–4 days. However, many women do not know their LMP date with certainty or have irregular cycles, reducing accuracy. In these cases, ultrasound dating is necessary. Clinical Pearl: Always ask the woman, "Do you know the first day of your last menstrual period?" Record the actual date, not an approximation. Ask about cycle regularity: "Are your periods usually 28 days apart?" Document this information as it affects the reliability of the calculated EDD. If the woman is uncertain of her LMP or has very irregular cycles, ultrasound dating is indicated. **Ultrasound Dating (Gold Standard in Modern Obstetrics)** Ultrasound provides accurate gestational age estimation based on fetal biometric measurements. The accuracy of ultrasound dating varies by trimester: • **First trimester (11–14 weeks)**: Accuracy ±3–5 days. Measured by crown-rump length (CRL). A CRL of 45–84 mm corresponds to 11–14 weeks. • **Second trimester (15–20 weeks)**: Accuracy ±1–2 weeks. Measured by biparietal diameter (BPD, the widest diameter of the fetal head measured on a transverse view), head circumference (HC), femur length (FL), and other parameters. • **Third trimester (>20 weeks)**: Accuracy ±2–3 weeks. Measured by BPD, HC, FL, and abdominal circumference (AC). Accuracy decreases in the third trimester due to normal biological variation in fetal size among individuals. Clinically, the earliest ultrasound (first trimester) is the most accurate for dating. If there is a discrepancy between the LMP-based EDD and the first-trimester ultrasound EDD of >5 days, the ultrasound dating is typically accepted as more reliable. If first-trimester ultrasound is not available and second-trimester ultrasound shows a discrepancy of >2 weeks from LMP dating, the ultrasound EDD should be used. Third-trimester ultrasound should not be used to change the EDD unless there is a discrepancy of >3–4 weeks from earlier dating. Clinical Pearl: In the Philippines, where ultrasound availability varies significantly by region and facility level, ideally all pregnant women should have at least one ultrasound in the first or early second trimester for dating and to detect major anomalies and multiple gestation. In settings where ultrasound is unavailable, careful LMP dating using Naegele's rule, combined with clinical assessment (fundal height, quickening), is used. **McDonald's Rule: Fundal Height as an Indicator of Gestational Age** Fundal height (the distance from the top of the symphysis pubis to the top of the uterine fundus, measured with a tape measure) can serve as a rough estimate of gestational age, particularly in the second and third trimesters. **McDonald's Rule states: After 20 weeks of gestation, the fundal height in centimeters approximately equals the number of weeks of gestation (±2 weeks).** For example: • At 20 weeks, fundal height is ~20 cm (at the level of the umbilicus). • At 24 weeks, fundal height is ~24 cm. • At 30 weeks, fundal height is ~30 cm. • At 36 weeks, fundal height is ~36 cm (near the xiphoid process). Before 20 weeks, fundal height is less predictive. Palpable landmarks include: • ~12 weeks: fundus palpable just above the symphysis pubis. • ~16 weeks: fundus midway between symphysis and umbilicus. • ~20 weeks: fundus at the umbilicus. McDonald's rule has significant limitations: it is inaccurate in obese women (layer of subcutaneous fat obscures landmarks), in women with short or tall stature, in multiple pregnancies, and in conditions affecting uterine size (polyhydramnios, oligohydramnios, fibroids, adenomyosis). Fundal height below expected levels may suggest fetal growth restriction or oligohydramnios; fundal height above expected levels may suggest polyhydramnios, multiple pregnancy, or excessive maternal weight gain. Slowing of fundal height growth from one visit to the next (when accounting for measurement error) warrants further assessment with ultrasound. Clinical Pearl: Measure fundal height at each prenatal visit in the same manner (woman supine or semi-sitting, measuring tape placed at the top of the symphysis pubis and extended to the highest point of the fundus in the midline). Record the measurement and graph it over time; a curve that plateaus or falls suggests growth problems. Use fundal height as a screening tool; confirm with ultrasound if discrepancies are found. **GTPAL/Gravida-Para Notation: Recording Obstetric History** As part of estimating due date and assessing pregnancy risk, record the woman's obstetric history using the **GTPAL** or **gravida-para** notation: • **G (Gravida)**: Total number of pregnancies, including the current one. Gravidity includes all pregnancies regardless of outcome. • **T (Term births)**: Number of pregnancies delivered at ≥37 weeks (single or multiple gestation; counts as one T). • **P (Preterm births)**: Number of pregnancies delivered between 20–36⁶ weeks. • **A (Abortions)**: Number of pregnancies ending in loss <20 weeks (spontaneous or induced abortion). • **L (Living children)**: Number of living children currently. Example: A woman who is now pregnant with one prior full-term vaginal delivery with a living child and one prior miscarriage at 12 weeks is: **G3 T1 P0 A1 L1** (gravida 3, term 1, preterm 0, abortion 1, living 1). The current pregnancy makes her gravida 3. Some institutions use a simpler notation: **G/P** (gravida/para). **Para** sometimes is subdivided into **T/P/A/L** or noted as a single number representing the number of deliveries ≥20 weeks. Clinical significance of GTPAL: • Gravidity: Grand multiparity (≥5 prior pregnancies) increases risks of hemorrhage, anemia, and uterine complications. • Parity: A woman who has never delivered (nulliparous) has different risks and management than a multiparous woman (has delivered before). Preterm or premature rupture of membranes (PROM) history increases risk in the current pregnancy. • Abortions: Prior miscarriage or termination may affect maternal attachment and anxiety in the current pregnancy; a history of multiple losses (recurrent pregnancy loss, defined as ≥3 consecutive losses) warrants investigation for causes (chromosomal abnormality, uterine anomaly, thrombophilia, infections) and may require specialized interventions in the current pregnancy (anticoagulation, progesterone supplementation, or other therapies depending on cause). Clinical Pearl: Record GTPAL carefully and completely; it provides a quick snapshot of the woman's obstetric history and helps identify risk factors. Use this information to tailor prenatal counseling and screening. **Calculating Gestational Age at a Given Date** Once the EDD is established, you can calculate the woman's gestational age at any given date. Simply count the number of days from the LMP to the given date and divide by 7 (days per week): **Gestational age (weeks) = (Today's date − LMP date) ÷ 7** Alternatively, count weeks and days. For example, if LMP is January 1, 2025, and today is March 22, 2025 (80 days later), the gestational age is 11 weeks 3 days (80 days ÷ 7 = 11.43 weeks, or 11 weeks plus 3 days). Clinical Pearl: Accurate dating is crucial for appropriate screening and management. If a woman presents for the first time in the third trimester without prior dating ultrasound, do your best to obtain an accurate LMP date, perform a thorough clinical assessment, and obtain ultrasound if available to estimate gestational age and plan delivery appropriately.

Pregnancy is fundamentally a developmental crisis—a major life transition that profoundly affects the woman's psychological state, sense of identity, relationships, and emotional well-being. Understanding the psychological dimension of pregnancy is essential for holistic nursing care that addresses not only physical needs but also emotional and social support. The nurse must recognize normal emotional fluctuations, support the woman's psychological adaptation, screen for mental health complications, and involve the partner and family in prenatal care. **Rubin's Maternal Tasks of Pregnancy** Psychiatrist Reva Rubin, in her seminal work, described four major psychological tasks that the pregnant woman must accomplish to adapt to pregnancy and prepare for motherhood. These tasks are not necessarily completed sequentially; they overlap and recur throughout pregnancy and even into the postpartum period. **Task 1: Ensuring Safe Passage for Self and Baby** This task involves the woman's concern about her own health and survival during pregnancy and birth, and her anxiety about the baby's health and viability. She seeks reassurance through prenatal care, learns about pregnancy changes and labor, and may engage in protective behaviors (taking prenatal vitamins, avoiding harmful substances, following healthcare advice). This task reflects her growing sense of responsibility for another human being. **Task 2: Seeking Acceptance of the Baby by Others** This task involves seeking confirmation from family, partner, friends, and healthcare providers that the pregnancy is acceptable and the baby will be welcomed. The woman may seek explicit verbal affirmation (e.g., "Are you happy about the pregnancy?" to her partner), may present her pregnant body with pride (sometimes called "wearing the pregnancy" publicly), and is sensitive to others' reactions. This task is particularly important in cultures where family approval is paramount, and it can be especially challenging for women experiencing unintended pregnancy, social disapproval, or relationship instability. In the Philippines, where extended family is often central to decision-making and child-rearing, involvement of family members in prenatal care and birth planning can facilitate this task. **Task 3: Binding-In (Maternal Attachment)** This task involves the gradual development of emotional attachment to the fetus, the beginning of the mother-infant relationship. Early in pregnancy, the fetus may feel like an abstract concept; as pregnancy progresses, particularly with quickening (16–20 weeks), the baby becomes increasingly real and separate. The woman engages in behaviors that enhance attachment: talking to the baby, placing hands on her abdomen, imagining the baby's appearance and personality, and selecting a name. By the third trimester, the woman's thoughts are often preoccupied with the baby. Attachment is enhanced by confirmation of the baby's presence and well-being (seeing the fetus on ultrasound, hearing fetal heart tones, feeling movements). Disruptions in binding-in (such as receiving news of fetal abnormality, fetal death, or in the case of unintended pregnancy) can cause psychological distress. The nurse can enhance binding-in by facilitating opportunities for ultrasound viewing, teaching fetal movement counting, and validating the woman's feelings and questions. **Task 4: Giving of Oneself** This task involves the woman's preparation to relinquish her previous life (freedom, body, schedule, identity) to become a mother. She begins to reorganize her life priorities, may adjust her work situation, and gradually accepts that her needs may be subordinated to those of her child. This task can be emotionally complex, involving both excitement and ambivalence about the loss of autonomy and pre-pregnancy lifestyle. The woman may grieve the end of certain phases of her life while embracing her new identity as a mother. Clinical Pearl: Use Rubin's framework when assessing the pregnant woman's psychological adaptation. Ask her directly: "How do you feel about being pregnant?" "How have family and friends reacted?" "Have you thought about what the baby will look like?" "What are you most looking forward to? Most worried about?" These questions open dialogue about her emotional state and help you identify women struggling with ambivalence, lack of support, or anxiety that may require additional counseling or referral. **Emotional Patterns Across the Three Trimesters** The pregnant woman's emotional state and preoccupations typically evolve in a somewhat predictable pattern across the three trimesters, though individual variation is significant. **First Trimester: Ambivalence and Denial** Even in planned, wanted pregnancies, the first trimester is often characterized by **ambivalence**—mixed feelings about the pregnancy. The woman may simultaneously feel joy and grief, excitement and fear, readiness and uncertainty. This ambivalence is normal and does not indicate a lack of desire for the baby or poor maternal capacity; it reflects the profound changes and adjustments ahead. The woman may focus on herself rather than the baby: "Am I really pregnant?" "How will this change my life?" "What about my career/education/plans?" Concerns about miscarriage are common, and the woman may deny or minimize the pregnancy emotionally as a protective mechanism, avoiding excessive bonding or planning until she feels the pregnancy is secure (often at 12–13 weeks, the traditional point of sharing news publicly, or after hearing fetal heart tones). Nausea, fatigue, and breast tenderness are prominent physical experiences that dominate her awareness. The woman may be more focused on managing these discomforts than on the abstract fetus. Mood lability (rapid mood swings) is common, driven by hormonal changes, anxiety, and the stress of adaptation. Nursing role: Normalize ambivalence; reassure the woman that it is normal to have mixed feelings about pregnancy, even a wanted one. Assess for excessive anxiety or depressive symptoms that might require intervention. Provide education about early pregnancy changes and milestones to come (quickening, viability, due date calculations), which help make the pregnancy feel more real and less abstract. **Second Trimester: Acceptance and Introspection** As the second trimester progresses, particularly with quickening (16–20 weeks), most women experience a shift toward **acceptance** of the pregnancy. The baby feels real now—the woman feels it moving inside her. She often becomes more introspective, withdrawn from external activities, and increasingly focused inward on the pregnancy and the baby. This is sometimes called "maternal introversion." The woman begins detailed imagination of the baby ("Will it have my nose or my partner's?"), engages in attachment behaviors, and may purchase baby items or prepare the nursery. Physically, the second trimester is often the "honeymoon phase" of pregnancy: morning sickness has usually resolved, the woman feels more energized than in the first trimester, her abdomen is noticeably rounded (making the pregnancy visible to others), and she typically feels the baby moving frequently. Many women report feeling most attractive and comfortable in their pregnant body during the second trimester. This is an optimal time for the woman to engage in prenatal education, partner involvement, and planning for birth. However, body image concerns may emerge: as her body changes, the woman may worry about stretch marks, weight gain, or whether her partner will still find her attractive. Some women struggle with the loss of control over their body or feel that their body is no longer their own. The nurse can address these concerns by normalizing body changes, affirming the beauty and functionality of the pregnant body, and encouraging open communication with the partner. Nursing role: Support the woman's introspection as adaptive and healthy. Encourage activities that enhance bonding (ultrasound viewing, fetal movement counting, naming the baby). Facilitate partner involvement in prenatal care and education. Address body image concerns with reassurance and information about postpartum recovery. Begin preparation for labor, birth, and parenting. **Third Trimester: Preparation and Anticipation** In the third trimester, the focus shifts to preparation for labor, birth, and parenthood. The woman often experiences a nesting instinct—an urge to prepare the home, organize baby items, clean, and ensure everything is ready. This is adaptive and normal. Simultaneously, anxiety about labor increases: "Will I be able to handle the pain?" "What if something goes wrong?" "What if my baby is not healthy?" Some women experience dreams or fantasies about labor and birth, which may be reassuring or frightening. Discomforts increase: back pain, pelvic pressure, urinary frequency, leg cramps, and sleep disruption become prominent as the woman's heavy uterus presses on various structures. Fatigue intensifies, and the woman may feel "ready to be done" with pregnancy by term. Braxton Hicks contractions often increase in frequency and intensity, which can be alarming if the woman mistakes them for true labor. Lightening (the descent of the fetal head into the pelvis, typically 2–4 weeks before term) can be obvious (the woman notices she can breathe more easily) or subtle. Emotion in the third trimester includes both anticipation ("I can't wait to meet my baby") and anxiety (about health risks, labor pain, unknown challenges of parenthood). The woman may seek reassurance through frequent healthcare visits and increased questioning. Some women experience depression or anxiety in the third trimester, which should be screened for and addressed. Nursing role: Teach labor preparedness (signs of true labor, when to come to the hospital, what to expect). Reassure about Braxton Hicks contractions and other late-pregnancy phenomena. Address fears about labor in a compassionate, reality-based way (neither dismissing nor catastrophizing). Facilitate childbirth education, partner involvement, and planning for support during labor. Assess for depression or anxiety. Discuss postpartum expectations, including baby care, recovery, and adjustment to parenthood. Clinical Pearl: Use the framework of "first trimester: ambivalence → second trimester: acceptance → third trimester: preparation" to assess whether a woman's emotional state is progressing normally or whether she is struggling with adaptation. A woman still intensely denying the pregnancy at 6 months, or increasingly anxious as term approaches, may benefit from extra support or counseling. **The Partner's Experience: Couvade Syndrome** While the pregnant woman's physical and emotional changes are obvious, her partner also typically undergoes psychological changes. **Couvade syndrome** (from the French word "couvade," meaning to hatch or incubate) refers to the experience of pregnancy-like symptoms in the expectant father or partner. The partner may experience nausea, appetite changes, weight gain, fatigue, or mood swings that mirror the pregnant woman's symptoms. While couvade syndrome is not universally experienced and its mechanisms are not entirely clear, it is thought to reflect increased empathy, emotional engagement with the pregnancy, and psychological identification with the pregnant woman. Moreover, partners often experience their own emotional responses to pregnancy: anticipation and joy about fatherhood or co-parenthood, anxiety about the health and well-being of the baby and partner, concern about financial responsibilities, and questions about how parenthood will affect their relationship and identity. Partners may feel excluded from the pregnancy experience (the physical changes, the direct connection to the baby) or may struggle to understand the woman's emotional and physical experience. Clinical Pearl: Include the partner in prenatal care whenever possible. Ask about their feelings and concerns. Provide opportunities for partner involvement: attending prenatal appointments, hearing fetal heart tones, feeling the baby kick, attending childbirth education. This enhances partner attachment to the baby and his/her sense of participation in the pregnancy and birth, and can strengthen the couple's relationship during this transition. **Body Image, Sexuality, and Relationship Changes in Pregnancy** Pregnancy profoundly affects the woman's perception of her body. Some women feel beautiful, powerful, and sensual in their pregnant body; others feel uncomfortable, unattractive, or alienated from their body as it changes beyond their control. **Body image concerns** include worry about stretch marks, weight gain (which some women fear they will never lose), changes in breast size and shape, swelling, and the visibility of the pregnant abdomen. In some cultures or within certain social groups, pregnant bodies are highly valued and celebrated; in others, there is greater emphasis on pre-pregnancy appearance, and pregnant women may feel they are less attractive or sexually desirable. The nurse can address body image concerns by affirming the beauty, functionality, and strength of the pregnant body; normalizing temporary changes that will resolve postpartum; and encouraging the woman to focus on what her body can do (grow a baby, birth a baby, nurse a baby) rather than purely aesthetic appearance. **Sexuality and sexual activity** are often affected by pregnancy. Some women report increased sexual interest and pleasure due to increased blood flow to genital tissues, breast sensitivity, and the psychological connection to pregnancy; others report decreased interest due to fatigue, body discomfort, or psychological factors. Partners' sexual interest and attraction may also change. Open communication between partners about sexual feelings and preferences is important. Standard prenatal care includes counseling that sexual activity is safe in normal pregnancy (unless there are specific contraindications such as rupture of membranes, placenta previa, or incompetent cervix) and can continue until labor begins. **Relationship changes** are common. The couple transitions from being a dyad to becoming a triad (parents plus child). Some couples grow closer during pregnancy, bonded by excitement about the baby and shared anticipation; others experience distance or conflict as the woman focuses on the pregnancy and the partner feels less attention or intimacy. If there are pre-existing relationship problems or poor communication, pregnancy can exacerbate them. The nurse should assess the quality of the couple's relationship and watch for signs of intimate partner violence (IPV), which can begin or worsen during pregnancy and carries serious risks to maternal and fetal health. Clinical Pearl: Ask the woman about her relationship with her partner: "How are things between you two?" "Does he support your pregnancy?" "Do you feel safe with him?" Screen for IPV ("Has your partner ever hurt you, threatened you, or made you afraid?") at each prenatal visit in a private, non-judgmental manner. In the Philippines, where IPV is unfortunately common and cultural and religious norms may discourage women from leaving unsafe relationships, empathetic, non-judgmental screening and appropriate referral (to social services, shelters, counseling) are essential. **Maternal Attachment and Bonding** Maternal attachment—the emotional bond between mother and baby—begins during pregnancy and intensifies after birth. Factors that enhance prenatal attachment include: • **Confirmation of pregnancy and viability**: Seeing the fetus on ultrasound, hearing fetal heart tones, and feeling fetal movement all make the baby feel real and separate. • **Positive maternal identity**: The woman's previous identification as childless shifts toward seeing herself as a mother. • **Planning and preparation**: Choosing baby names, selecting nursery furniture, and imagining future activities with the baby facilitate bonding. • **Cultural and family support**: Family and cultural traditions that celebrate pregnancy and welcome the baby enhance attachment. • **Partner support**: A supportive, engaged partner enhances the woman's confidence in her ability to mother and her emotional well-being. Factors that impede attachment include: • **Unintended pregnancy**: The woman may not have planned to become pregnant and may feel ambivalent or resentful about the pregnancy. • **Fetal abnormality or illness**: News of fetal problems can precipitate grief and anxiety and temporarily disrupt bonding (though many women successfully rebond after processing the information). • **Maternal mental health problems**: Depression or anxiety can impair the woman's emotional engagement with the pregnancy. • **Lack of support**: Social isolation, unsupportive partner, or family disapproval can leave the woman feeling unsupported and ambivalent. • **Circumstances of conception**: Pregnancy resulting from sexual assault or coercive circumstances can be psychologically traumatic and may impair bonding. The nurse's role is to assess the woman's attachment to the pregnancy and baby, identify factors supporting or impeding bonding, and facilitate interventions to enhance attachment when needed. For a woman with an unintended pregnancy, the nurse can provide non-judgmental support, accurate information about her options (continuing the pregnancy, adoption, or termination, where legally and culturally available), and continued care regardless of the woman's choice. For a woman with fetal abnormality, the nurse can provide emotional support, accurate information about the condition and prognosis, and connection to support groups or counseling. For a woman with depression or anxiety, appropriate screening and referral for mental health treatment is essential. Clinical Pearl: The goal is not to pressure all women into immediate, intense bonding, but rather to create conditions that support each woman's unique emotional journey and to identify and address barriers to healthy attachment. **Psychological Screening and Mental Health in Pregnancy** Pregnancy is a time of heightened vulnerability to mental health problems. Depression, anxiety, and other psychiatric conditions can develop or worsen in pregnancy; conversely, some women with pre-existing mental health conditions experience improvement. Approximately 15–20% of pregnant women experience depressive or anxiety symptoms; many of these go undiagnosed and untreated, missing opportunities for intervention. Screening for depression should occur at the first prenatal visit and periodically throughout pregnancy. The PHQ-2 (two-question screener) or PHQ-9 (more comprehensive nine-item screening tool) are brief, evidence-based tools that can be used in busy clinical settings. Questions typically ask about depressed mood, loss of interest in activities, sleep changes, fatigue, appetite changes, feelings of worthlessness, and difficulty concentrating—symptoms that can overlap with normal pregnancy experiences but which, when pervasive and impairing, suggest clinical depression. Anxiety disorders and panic attacks also occur in pregnancy. Anxiety may focus on health concerns (about the baby or maternal health), fears of labor and birth, or more generalized anxiety. The GAD-7 (Generalized Anxiety Disorder Scale) is a brief screening tool for anxiety disorders. Screening should also include intimate partner violence, substance use, and suicidal ideation. A woman with untreated depression or anxiety, or in an abusive relationship, is at higher risk for poor pregnancy outcomes and postpartum complications. Treatment options in pregnancy include cognitive-behavioral therapy (first-line), selective serotonin reuptake inhibitors (SSRIs, which are generally considered safe in pregnancy), and other interventions depending on the severity and type of condition. Clinical Pearl: As a nurse providing prenatal care, take mental health screening seriously. If a woman screens positive for depression, anxiety, or intimate partner violence, provide appropriate referral for specialist assessment and treatment. Normalize mental health issues: "Many pregnant women experience depression or anxiety; it is not a personal failing, and treatment is available and effective." Follow up on referrals to ensure the woman accesses care. **Nursing Interventions to Support Psychological Adaptation** • **Provide accurate, reassuring information** about normal pregnancy changes, common discomforts, and what to expect across the three trimesters. This reduces anxiety born of uncertainty. • **Normalize the pregnancy experience**: "It is normal to feel tired in the first trimester and third trimester." "Many women experience ambivalence about pregnancy." "Your mood swings are driven by hormones, not a sign you will be a bad mother." • **Facilitate attachment**: Encourage viewing ultrasounds, hearing fetal heart tones, and feeling fetal movement. Ask the woman if she has chosen a name and what she imagines about the baby. • **Assess and support the couple's relationship**: Ask about partner support, facilitate partner involvement in care, and provide couples communication guidance when appropriate. • **Address body image concerns**: Affirm the pregnant body, normalize temporary changes, and discuss postpartum recovery realistically. • **Provide coping strategies**: Teach relaxation techniques, encourage exercise (walking, prenatal yoga, swimming) as tolerated, discuss meaningful coping strategies (spiritual practices, time with supportive friends/family, creative outlets). • **Screen for mental health, IPV, and substance use**: Use brief, validated tools to identify women needing specialist referral. • **Involve the family and community**: In many cultures including Filipino culture, the pregnant woman's mother, sisters, and close community members play important roles in supporting pregnancy and preparing for motherhood. Facilitate their involvement when the woman desires it. • **Provide anticipatory guidance**: At each trimester, discuss what to expect emotionally and physically, what milestones are coming, and how to prepare.